美国卒中带和非卒中带居民卒中后高血压药物使用的比较。
A comparison of post-stroke hypertension medication use between US Stroke Belt and Non-Stroke Belt residents.
机构信息
Department of Chronic Disease Epidemiology, Yale University, New Haven, CT, USA.
Department of Biostatistics, Michigan School of Public Health, Ann Arbor, MI, USA.
出版信息
J Clin Hypertens (Greenwich). 2021 Jun;23(6):1260-1263. doi: 10.1111/jch.14213. Epub 2021 Feb 17.
Although hypertension is a contributing factor to higher stroke occurrence in the Stroke Belt, little is known about post-stroke hypertension medication use in Stroke Belt residents. Through the use of national Behavioral Risk Factor Surveillance System surveys from 2015, 2017, and 2019; we compared unadjusted and adjusted estimates of post-stroke hypertension medication use by Stroke Belt residence status. Similar levels of post-stroke hypertension medication use were observed between Stroke Belt residents (OR: 1.09, 95% CI: 0.89, 1.33) and non-Stroke Belt residents. After adjustment, Stroke Belt residents had 1.14 times the odds of post-stroke hypertension medication use (95% CI: 0.92, 1.41) compared to non-Stroke Belt residents. Findings from this study suggest that there is little difference between post-stroke hypertension medication use between Stroke Belt and non-Stroke Belt residents. However, further work is needed to assess whether use of other non-medicinal methods of post-stroke hypertension control differs by Stroke Belt residence status.
虽然高血压是“中风带”中风发生率较高的一个因素，但对于“中风带”居民中风后使用高血压药物的情况知之甚少。通过使用国家行为风险因素监测系统 2015 年、2017 年和 2019 年的调查数据，我们比较了居住在“中风带”和非“中风带”居民中风后使用高血压药物的未经调整和调整后的估计值。居住在“中风带”的居民（OR：1.09，95%CI：0.89，1.33）和非“中风带”居民的中风后高血压药物使用水平相似。调整后，与非“中风带”居民相比，“中风带”居民中风后使用高血压药物的几率高出 1.14 倍（95%CI：0.92，1.41）。本研究结果表明，“中风带”和非“中风带”居民中风后高血压药物使用情况差异不大。然而，需要进一步研究评估“中风带”居民的中风后高血压控制是否存在其他非药物治疗方法的差异。
Zotero 插件